nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CYP2B6—chronic kidney failure	0.353	0.587	CbGaD
Nilotinib—CYP3A4—chronic kidney failure	0.136	0.225	CbGaD
Nilotinib—ABCB1—chronic kidney failure	0.113	0.188	CbGaD
Nilotinib—CYP2C9—cardial valve—chronic kidney failure	0.00488	0.0354	CbGeAlD
Nilotinib—PDGFRA—penis—chronic kidney failure	0.00394	0.0286	CbGeAlD
Nilotinib—MAPK8—artery—chronic kidney failure	0.0035	0.0254	CbGeAlD
Nilotinib—EPHB3—nerve—chronic kidney failure	0.00286	0.0208	CbGeAlD
Nilotinib—UGT1A1—urine—chronic kidney failure	0.0025	0.0182	CbGeAlD
Nilotinib—LYN—blood plasma—chronic kidney failure	0.00242	0.0176	CbGeAlD
Nilotinib—EPHA4—nerve—chronic kidney failure	0.00239	0.0173	CbGeAlD
Nilotinib—Imatinib—SLC22A2—chronic kidney failure	0.00225	0.347	CrCbGaD
Nilotinib—TEK—artery—chronic kidney failure	0.00201	0.0146	CbGeAlD
Nilotinib—MAPK14—blood plasma—chronic kidney failure	0.00167	0.0121	CbGeAlD
Nilotinib—FRK—renal system—chronic kidney failure	0.00161	0.0117	CbGeAlD
Nilotinib—FRK—gonad—chronic kidney failure	0.00145	0.0105	CbGeAlD
Nilotinib—CDC42BPB—renal system—chronic kidney failure	0.00136	0.00987	CbGeAlD
Nilotinib—CDC42BPB—cardiovascular system—chronic kidney failure	0.00134	0.00976	CbGeAlD
Nilotinib—CDC42BPB—urethra—chronic kidney failure	0.00134	0.0097	CbGeAlD
Nilotinib—CA1—nerve—chronic kidney failure	0.00132	0.00961	CbGeAlD
Nilotinib—UGT1A1—blood plasma—chronic kidney failure	0.00131	0.00948	CbGeAlD
Nilotinib—CDC42BPB—cortex of kidney—chronic kidney failure	0.00128	0.0093	CbGeAlD
Nilotinib—EPHB2—digestive system—chronic kidney failure	0.00126	0.00916	CbGeAlD
Nilotinib—MAPK8—renal system—chronic kidney failure	0.00123	0.00893	CbGeAlD
Nilotinib—CDC42BPB—gonad—chronic kidney failure	0.00122	0.00885	CbGeAlD
Nilotinib—BLK—blood—chronic kidney failure	0.00122	0.00883	CbGeAlD
Nilotinib—MAPK8—cardiovascular system—chronic kidney failure	0.00122	0.00882	CbGeAlD
Nilotinib—MAPK8—urethra—chronic kidney failure	0.00121	0.00877	CbGeAlD
Nilotinib—CSF1R—blood plasma—chronic kidney failure	0.00121	0.00875	CbGeAlD
Nilotinib—MAPK8—kidney—chronic kidney failure	0.00119	0.00863	CbGeAlD
Nilotinib—MAPK8—cortex of kidney—chronic kidney failure	0.00116	0.00841	CbGeAlD
Nilotinib—CDC42BPB—digestive system—chronic kidney failure	0.00112	0.0081	CbGeAlD
Nilotinib—MAPK8—gonad—chronic kidney failure	0.0011	0.00801	CbGeAlD
Nilotinib—EPHA6—gonad—chronic kidney failure	0.0011	0.00801	CbGeAlD
Nilotinib—KIT—blood plasma—chronic kidney failure	0.00109	0.00795	CbGeAlD
Nilotinib—TIE1—cardiovascular system—chronic kidney failure	0.00105	0.00765	CbGeAlD
Nilotinib—CYP2C9—urine—chronic kidney failure	0.00105	0.00764	CbGeAlD
Nilotinib—TIE1—urethra—chronic kidney failure	0.00105	0.0076	CbGeAlD
Nilotinib—CA4—nerve—chronic kidney failure	0.00103	0.00751	CbGeAlD
Nilotinib—MAPK8—digestive system—chronic kidney failure	0.00101	0.00732	CbGeAlD
Nilotinib—CA1—blood plasma—chronic kidney failure	0.001	0.00727	CbGeAlD
Nilotinib—EPHB3—urethra—chronic kidney failure	0.000996	0.00723	CbGeAlD
Nilotinib—MAPK8—blood—chronic kidney failure	0.000961	0.00698	CbGeAlD
Nilotinib—HCK—urethra—chronic kidney failure	0.000915	0.00665	CbGeAlD
Nilotinib—CA7—renal system—chronic kidney failure	0.000912	0.00662	CbGeAlD
Nilotinib—LYN—blood—chronic kidney failure	0.000887	0.00644	CbGeAlD
Nilotinib—CA7—kidney—chronic kidney failure	0.000882	0.0064	CbGeAlD
Nilotinib—MAP4K1—blood—chronic kidney failure	0.000873	0.00634	CbGeAlD
Nilotinib—EPHA4—urethra—chronic kidney failure	0.000832	0.00604	CbGeAlD
Nilotinib—EPHB3—digestive system—chronic kidney failure	0.000832	0.00604	CbGeAlD
Nilotinib—CA3—cardiovascular system—chronic kidney failure	0.000827	0.006	CbGeAlD
Nilotinib—EPHB4—nephron tubule—chronic kidney failure	0.000814	0.00591	CbGeAlD
Nilotinib—Imatinib—PTGS1—chronic kidney failure	0.000809	0.125	CrCbGaD
Nilotinib—CYP3A4—urine—chronic kidney failure	0.000802	0.00582	CbGeAlD
Nilotinib—EPHA2—nephron tubule—chronic kidney failure	0.000799	0.0058	CbGeAlD
Nilotinib—BRAF—blood—chronic kidney failure	0.000799	0.0058	CbGeAlD
Nilotinib—CYP2D6—urine—chronic kidney failure	0.000789	0.00573	CbGeAlD
Nilotinib—MAPK14—renal system—chronic kidney failure	0.000781	0.00567	CbGeAlD
Nilotinib—MAPK14—cardiovascular system—chronic kidney failure	0.000772	0.0056	CbGeAlD
Nilotinib—FGR—cardiovascular system—chronic kidney failure	0.000769	0.00558	CbGeAlD
Nilotinib—Ponatinib—CYP3A4—chronic kidney failure	0.000767	0.118	CrCbGaD
Nilotinib—HCK—digestive system—chronic kidney failure	0.000764	0.00555	CbGeAlD
Nilotinib—LCK—urethra—chronic kidney failure	0.000764	0.00555	CbGeAlD
Nilotinib—FGR—urethra—chronic kidney failure	0.000764	0.00555	CbGeAlD
Nilotinib—EPHA4—gonad—chronic kidney failure	0.00076	0.00552	CbGeAlD
Nilotinib—MAPK14—kidney—chronic kidney failure	0.000755	0.00548	CbGeAlD
Nilotinib—CA7—digestive system—chronic kidney failure	0.000748	0.00543	CbGeAlD
Nilotinib—Imatinib—CYP2C19—chronic kidney failure	0.000743	0.114	CrCbGaD
Nilotinib—EPHB4—renal system—chronic kidney failure	0.00074	0.00538	CbGeAlD
Nilotinib—EPHB4—cardiovascular system—chronic kidney failure	0.000732	0.00531	CbGeAlD
Nilotinib—HCK—blood—chronic kidney failure	0.000728	0.00529	CbGeAlD
Nilotinib—EPHB4—urethra—chronic kidney failure	0.000727	0.00528	CbGeAlD
Nilotinib—ABL2—blood—chronic kidney failure	0.000724	0.00525	CbGeAlD
Nilotinib—EPHA2—cardiovascular system—chronic kidney failure	0.000718	0.00521	CbGeAlD
Nilotinib—EPHB4—kidney—chronic kidney failure	0.000716	0.0052	CbGeAlD
Nilotinib—EPHA2—urethra—chronic kidney failure	0.000713	0.00518	CbGeAlD
Nilotinib—TEK—renal system—chronic kidney failure	0.000709	0.00514	CbGeAlD
Nilotinib—TEK—cardiovascular system—chronic kidney failure	0.0007	0.00508	CbGeAlD
Nilotinib—EPHB4—cortex of kidney—chronic kidney failure	0.000697	0.00506	CbGeAlD
Nilotinib—TEK—urethra—chronic kidney failure	0.000696	0.00505	CbGeAlD
Nilotinib—TEK—kidney—chronic kidney failure	0.000685	0.00497	CbGeAlD
Nilotinib—TEK—cortex of kidney—chronic kidney failure	0.000667	0.00484	CbGeAlD
Nilotinib—EPHB6—urethra—chronic kidney failure	0.000665	0.00483	CbGeAlD
Nilotinib—EPHA4—blood—chronic kidney failure	0.000662	0.00481	CbGeAlD
Nilotinib—CA9—digestive system—chronic kidney failure	0.000657	0.00477	CbGeAlD
Nilotinib—CA2—blood plasma—chronic kidney failure	0.000649	0.00471	CbGeAlD
Nilotinib—PDGFRA—renal system—chronic kidney failure	0.000642	0.00466	CbGeAlD
Nilotinib—MAPK14—digestive system—chronic kidney failure	0.000641	0.00465	CbGeAlD
Nilotinib—Ponatinib—ABCB1—chronic kidney failure	0.000639	0.0985	CrCbGaD
Nilotinib—FGR—digestive system—chronic kidney failure	0.000638	0.00463	CbGeAlD
Nilotinib—EPHB6—cortex of kidney—chronic kidney failure	0.000638	0.00463	CbGeAlD
Nilotinib—PDGFRA—cardiovascular system—chronic kidney failure	0.000634	0.00461	CbGeAlD
Nilotinib—CYP2C8—blood plasma—chronic kidney failure	0.000618	0.00449	CbGeAlD
Nilotinib—UGT1A1—renal system—chronic kidney failure	0.000612	0.00445	CbGeAlD
Nilotinib—MAPK14—blood—chronic kidney failure	0.00061	0.00443	CbGeAlD
Nilotinib—LCK—blood—chronic kidney failure	0.000608	0.00441	CbGeAlD
Nilotinib—FGR—blood—chronic kidney failure	0.000608	0.00441	CbGeAlD
Nilotinib—EPHB4—digestive system—chronic kidney failure	0.000607	0.00441	CbGeAlD
Nilotinib—EPHA2—digestive system—chronic kidney failure	0.000596	0.00433	CbGeAlD
Nilotinib—CA12—renal system—chronic kidney failure	0.000592	0.0043	CbGeAlD
Nilotinib—UGT1A1—kidney—chronic kidney failure	0.000592	0.0043	CbGeAlD
Nilotinib—EPHB4—blood—chronic kidney failure	0.000579	0.0042	CbGeAlD
Nilotinib—PDGFRA—gonad—chronic kidney failure	0.000576	0.00418	CbGeAlD
Nilotinib—CA12—kidney—chronic kidney failure	0.000573	0.00416	CbGeAlD
Nilotinib—MAP2K5—cardiovascular system—chronic kidney failure	0.000572	0.00415	CbGeAlD
Nilotinib—MAP2K5—urethra—chronic kidney failure	0.000569	0.00413	CbGeAlD
Nilotinib—EPHA2—blood—chronic kidney failure	0.000568	0.00412	CbGeAlD
Nilotinib—KIT—nephron tubule—chronic kidney failure	0.000565	0.0041	CbGeAlD
Nilotinib—CSF1R—cardiovascular system—chronic kidney failure	0.000558	0.00405	CbGeAlD
Nilotinib—CSF1R—urethra—chronic kidney failure	0.000555	0.00403	CbGeAlD
Nilotinib—CYP2B6—blood plasma—chronic kidney failure	0.000554	0.00403	CbGeAlD
Nilotinib—TEK—blood—chronic kidney failure	0.000554	0.00402	CbGeAlD
Nilotinib—CYP2C9—blood plasma—chronic kidney failure	0.000549	0.00399	CbGeAlD
Nilotinib—MAP2K5—cortex of kidney—chronic kidney failure	0.000545	0.00396	CbGeAlD
Nilotinib—EPHB6—blood—chronic kidney failure	0.000529	0.00384	CbGeAlD
Nilotinib—PDGFRA—digestive system—chronic kidney failure	0.000527	0.00382	CbGeAlD
Nilotinib—KIT—renal system—chronic kidney failure	0.000513	0.00373	CbGeAlD
Nilotinib—KIT—cardiovascular system—chronic kidney failure	0.000507	0.00368	CbGeAlD
Nilotinib—CSF1R—gonad—chronic kidney failure	0.000507	0.00368	CbGeAlD
Nilotinib—KIT—urethra—chronic kidney failure	0.000504	0.00366	CbGeAlD
Nilotinib—UGT1A1—digestive system—chronic kidney failure	0.000502	0.00365	CbGeAlD
Nilotinib—PDGFRA—blood—chronic kidney failure	0.000502	0.00364	CbGeAlD
Nilotinib—PDGFRB—renal system—chronic kidney failure	0.000501	0.00364	CbGeAlD
Nilotinib—KIT—kidney—chronic kidney failure	0.000496	0.0036	CbGeAlD
Nilotinib—PDGFRB—cardiovascular system—chronic kidney failure	0.000495	0.0036	CbGeAlD
Nilotinib—PDGFRB—urethra—chronic kidney failure	0.000492	0.00357	CbGeAlD
Nilotinib—ABL1—nephron tubule—chronic kidney failure	0.000491	0.00357	CbGeAlD
Nilotinib—CA12—digestive system—chronic kidney failure	0.000486	0.00353	CbGeAlD
Nilotinib—PDGFRB—kidney—chronic kidney failure	0.000485	0.00352	CbGeAlD
Nilotinib—KIT—cortex of kidney—chronic kidney failure	0.000483	0.00351	CbGeAlD
Nilotinib—UGT1A1—blood—chronic kidney failure	0.000479	0.00347	CbGeAlD
Nilotinib—Imatinib—CYP3A4—chronic kidney failure	0.000472	0.0728	CrCbGaD
Nilotinib—PDGFRB—cortex of kidney—chronic kidney failure	0.000472	0.00343	CbGeAlD
Nilotinib—CA1—renal system—chronic kidney failure	0.000469	0.00341	CbGeAlD
Nilotinib—CA1—cardiovascular system—chronic kidney failure	0.000464	0.00337	CbGeAlD
Nilotinib—CSF1R—digestive system—chronic kidney failure	0.000464	0.00337	CbGeAlD
Nilotinib—KIT—gonad—chronic kidney failure	0.00046	0.00334	CbGeAlD
Nilotinib—CA1—kidney—chronic kidney failure	0.000454	0.00329	CbGeAlD
Nilotinib—MAP2K5—blood—chronic kidney failure	0.000453	0.00329	CbGeAlD
Nilotinib—PDGFRB—gonad—chronic kidney failure	0.000449	0.00326	CbGeAlD
Nilotinib—ABL1—renal system—chronic kidney failure	0.000447	0.00324	CbGeAlD
Nilotinib—CSF1R—blood—chronic kidney failure	0.000442	0.00321	CbGeAlD
Nilotinib—ABL1—cardiovascular system—chronic kidney failure	0.000441	0.0032	CbGeAlD
Nilotinib—ABL1—urethra—chronic kidney failure	0.000439	0.00319	CbGeAlD
Nilotinib—ABL1—kidney—chronic kidney failure	0.000432	0.00314	CbGeAlD
Nilotinib—KIT—digestive system—chronic kidney failure	0.000421	0.00306	CbGeAlD
Nilotinib—ABL1—cortex of kidney—chronic kidney failure	0.000421	0.00305	CbGeAlD
Nilotinib—CYP3A4—blood plasma—chronic kidney failure	0.000419	0.00304	CbGeAlD
Nilotinib—Imatinib—ALB—chronic kidney failure	0.000412	0.0635	CrCbGaD
Nilotinib—CYP2D6—blood plasma—chronic kidney failure	0.000412	0.00299	CbGeAlD
Nilotinib—PDGFRB—digestive system—chronic kidney failure	0.000411	0.00298	CbGeAlD
Nilotinib—CA4—nephron tubule—chronic kidney failure	0.000404	0.00293	CbGeAlD
Nilotinib—KIT—blood—chronic kidney failure	0.000401	0.00291	CbGeAlD
Nilotinib—ABL1—gonad—chronic kidney failure	0.000401	0.00291	CbGeAlD
Nilotinib—Imatinib—ABCB1—chronic kidney failure	0.000393	0.0606	CrCbGaD
Nilotinib—PDGFRB—blood—chronic kidney failure	0.000392	0.00284	CbGeAlD
Nilotinib—CA1—digestive system—chronic kidney failure	0.000385	0.0028	CbGeAlD
Nilotinib—CA4—renal system—chronic kidney failure	0.000367	0.00266	CbGeAlD
Nilotinib—CA1—blood—chronic kidney failure	0.000367	0.00266	CbGeAlD
Nilotinib—ABL1—digestive system—chronic kidney failure	0.000366	0.00266	CbGeAlD
Nilotinib—CA4—cardiovascular system—chronic kidney failure	0.000362	0.00263	CbGeAlD
Nilotinib—CA4—urethra—chronic kidney failure	0.00036	0.00262	CbGeAlD
Nilotinib—CA4—kidney—chronic kidney failure	0.000355	0.00258	CbGeAlD
Nilotinib—ABL1—blood—chronic kidney failure	0.000349	0.00253	CbGeAlD
Nilotinib—CA4—cortex of kidney—chronic kidney failure	0.000345	0.00251	CbGeAlD
Nilotinib—CA2—nephron tubule—chronic kidney failure	0.000335	0.00243	CbGeAlD
Nilotinib—ABCG2—nephron tubule—chronic kidney failure	0.00031	0.00225	CbGeAlD
Nilotinib—CA2—renal system—chronic kidney failure	0.000304	0.00221	CbGeAlD
Nilotinib—CA4—digestive system—chronic kidney failure	0.000301	0.00218	CbGeAlD
Nilotinib—CA2—cardiovascular system—chronic kidney failure	0.000301	0.00218	CbGeAlD
Nilotinib—ABCB1—blood plasma—chronic kidney failure	0.000296	0.00215	CbGeAlD
Nilotinib—CA2—kidney—chronic kidney failure	0.000294	0.00214	CbGeAlD
Nilotinib—CYP2C8—renal system—chronic kidney failure	0.00029	0.0021	CbGeAlD
Nilotinib—CA4—blood—chronic kidney failure	0.000287	0.00208	CbGeAlD
Nilotinib—CA2—cortex of kidney—chronic kidney failure	0.000286	0.00208	CbGeAlD
Nilotinib—CYP2B6—nephron tubule—chronic kidney failure	0.000286	0.00208	CbGeAlD
Nilotinib—CYP2C8—kidney—chronic kidney failure	0.00028	0.00203	CbGeAlD
Nilotinib—ABCG2—urethra—chronic kidney failure	0.000277	0.00201	CbGeAlD
Nilotinib—CYP2B6—renal system—chronic kidney failure	0.00026	0.00189	CbGeAlD
Nilotinib—CYP2B6—cardiovascular system—chronic kidney failure	0.000257	0.00186	CbGeAlD
Nilotinib—CYP2C9—cardiovascular system—chronic kidney failure	0.000254	0.00185	CbGeAlD
Nilotinib—CYP2B6—kidney—chronic kidney failure	0.000251	0.00182	CbGeAlD
Nilotinib—CA2—digestive system—chronic kidney failure	0.00025	0.00181	CbGeAlD
Nilotinib—CA2—blood—chronic kidney failure	0.000238	0.00173	CbGeAlD
Nilotinib—CYP2B6—gonad—chronic kidney failure	0.000233	0.00169	CbGeAlD
Nilotinib—CYP2C8—blood—chronic kidney failure	0.000226	0.00164	CbGeAlD
Nilotinib—ABCG2—blood—chronic kidney failure	0.00022	0.0016	CbGeAlD
Nilotinib—CYP2B6—digestive system—chronic kidney failure	0.000213	0.00155	CbGeAlD
Nilotinib—CYP2C9—digestive system—chronic kidney failure	0.000211	0.00153	CbGeAlD
Nilotinib—CYP2B6—blood—chronic kidney failure	0.000203	0.00147	CbGeAlD
Nilotinib—CYP2C9—blood—chronic kidney failure	0.000201	0.00146	CbGeAlD
Nilotinib—CYP3A4—renal system—chronic kidney failure	0.000196	0.00142	CbGeAlD
Nilotinib—CYP2D6—renal system—chronic kidney failure	0.000193	0.0014	CbGeAlD
Nilotinib—CYP3A4—kidney—chronic kidney failure	0.00019	0.00138	CbGeAlD
Nilotinib—CYP2D6—kidney—chronic kidney failure	0.000187	0.00136	CbGeAlD
Nilotinib—CYP3A4—digestive system—chronic kidney failure	0.000161	0.00117	CbGeAlD
Nilotinib—CYP2D6—digestive system—chronic kidney failure	0.000158	0.00115	CbGeAlD
Nilotinib—CYP3A4—blood—chronic kidney failure	0.000153	0.00111	CbGeAlD
Nilotinib—ABCB1—nephron tubule—chronic kidney failure	0.000153	0.00111	CbGeAlD
Nilotinib—CYP2D6—blood—chronic kidney failure	0.000151	0.0011	CbGeAlD
Nilotinib—ABCB1—renal system—chronic kidney failure	0.000139	0.00101	CbGeAlD
Nilotinib—ABCB1—cardiovascular system—chronic kidney failure	0.000137	0.000997	CbGeAlD
Nilotinib—ABCB1—urethra—chronic kidney failure	0.000136	0.000991	CbGeAlD
Nilotinib—ABCB1—kidney—chronic kidney failure	0.000134	0.000975	CbGeAlD
Nilotinib—ABCB1—cortex of kidney—chronic kidney failure	0.000131	0.00095	CbGeAlD
Nilotinib—ABCB1—gonad—chronic kidney failure	0.000125	0.000905	CbGeAlD
Nilotinib—ABCB1—digestive system—chronic kidney failure	0.000114	0.000827	CbGeAlD
Nilotinib—ABCB1—blood—chronic kidney failure	0.000109	0.000788	CbGeAlD
Nilotinib—LYN—Signaling Pathways—F2—chronic kidney failure	4.45e-06	1.76e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—KRAS—chronic kidney failure	4.45e-06	1.75e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NFKB1—chronic kidney failure	4.45e-06	1.75e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SERPINE1—chronic kidney failure	4.44e-06	1.75e-05	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—IL6—chronic kidney failure	4.44e-06	1.75e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—NFKB1—chronic kidney failure	4.44e-06	1.75e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LIPC—chronic kidney failure	4.43e-06	1.75e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	4.43e-06	1.75e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IGF1—chronic kidney failure	4.42e-06	1.74e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—RELA—chronic kidney failure	4.42e-06	1.74e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—chronic kidney failure	4.42e-06	1.74e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—chronic kidney failure	4.4e-06	1.73e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—RELA—chronic kidney failure	4.38e-06	1.73e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SCARB1—chronic kidney failure	4.38e-06	1.73e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NGF—chronic kidney failure	4.37e-06	1.72e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	4.37e-06	1.72e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—NFKB1—chronic kidney failure	4.34e-06	1.71e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—SERPINE1—chronic kidney failure	4.34e-06	1.71e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS1—chronic kidney failure	4.34e-06	1.71e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—NFKB1—chronic kidney failure	4.32e-06	1.7e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	4.3e-06	1.7e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IRS1—chronic kidney failure	4.3e-06	1.7e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	4.28e-06	1.69e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR5—chronic kidney failure	4.26e-06	1.68e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SREBF1—chronic kidney failure	4.25e-06	1.68e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—VEGFA—chronic kidney failure	4.25e-06	1.67e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NOS3—chronic kidney failure	4.24e-06	1.67e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	4.23e-06	1.67e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CAT—chronic kidney failure	4.23e-06	1.67e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—RELA—chronic kidney failure	4.22e-06	1.66e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—F2—chronic kidney failure	4.22e-06	1.66e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IRS1—chronic kidney failure	4.21e-06	1.66e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SERPINE1—chronic kidney failure	4.2e-06	1.66e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DDC—chronic kidney failure	4.19e-06	1.65e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—chronic kidney failure	4.14e-06	1.63e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS3—chronic kidney failure	4.14e-06	1.63e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ALB—chronic kidney failure	4.14e-06	1.63e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HMGCR—chronic kidney failure	4.14e-06	1.63e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SCARB1—chronic kidney failure	4.13e-06	1.63e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NFKB1—chronic kidney failure	4.12e-06	1.62e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ABCB1—chronic kidney failure	4.12e-06	1.62e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SCARB1—chronic kidney failure	4.09e-06	1.61e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS1—chronic kidney failure	4.09e-06	1.61e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—KRAS—chronic kidney failure	4.07e-06	1.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	4.07e-06	1.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	4.07e-06	1.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	4.07e-06	1.6e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—chronic kidney failure	4.06e-06	1.6e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.06e-06	1.6e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—chronic kidney failure	4.06e-06	1.6e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS1—chronic kidney failure	4.05e-06	1.6e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—FASN—chronic kidney failure	4.05e-06	1.6e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—VEGFA—chronic kidney failure	4.04e-06	1.59e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—KRAS—chronic kidney failure	4.01e-06	1.58e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOS3—chronic kidney failure	4.01e-06	1.58e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SREBF1—chronic kidney failure	4.01e-06	1.58e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—chronic kidney failure	4e-06	1.58e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IRS1—chronic kidney failure	3.99e-06	1.57e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—RELA—chronic kidney failure	3.99e-06	1.57e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IGF1—chronic kidney failure	3.99e-06	1.57e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	3.98e-06	1.57e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SREBF1—chronic kidney failure	3.97e-06	1.57e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—chronic kidney failure	3.97e-06	1.56e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NOS3—chronic kidney failure	3.96e-06	1.56e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—LPL—chronic kidney failure	3.92e-06	1.55e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IGF1—chronic kidney failure	3.9e-06	1.54e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—chronic kidney failure	3.9e-06	1.54e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HMGCR—chronic kidney failure	3.9e-06	1.54e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HMGCR—chronic kidney failure	3.86e-06	1.52e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—chronic kidney failure	3.85e-06	1.52e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—chronic kidney failure	3.85e-06	1.52e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—IL6—chronic kidney failure	3.84e-06	1.51e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—chronic kidney failure	3.82e-06	1.5e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—FASN—chronic kidney failure	3.81e-06	1.5e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	3.81e-06	1.5e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—KRAS—chronic kidney failure	3.8e-06	1.5e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP1A1—chronic kidney failure	3.79e-06	1.49e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—chronic kidney failure	3.79e-06	1.49e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTGS2—chronic kidney failure	3.79e-06	1.49e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SERPINE1—chronic kidney failure	3.79e-06	1.49e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—FASN—chronic kidney failure	3.78e-06	1.49e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RELA—chronic kidney failure	3.78e-06	1.49e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—chronic kidney failure	3.76e-06	1.48e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	3.75e-06	1.48e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NFKB1—chronic kidney failure	3.73e-06	1.47e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—chronic kidney failure	3.71e-06	1.46e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—KRAS—chronic kidney failure	3.71e-06	1.46e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SERPINE1—chronic kidney failure	3.71e-06	1.46e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IGF1—chronic kidney failure	3.7e-06	1.46e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NFKB1—chronic kidney failure	3.7e-06	1.46e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ABCA1—chronic kidney failure	3.69e-06	1.45e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	3.68e-06	1.45e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	3.68e-06	1.45e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—F2—chronic kidney failure	3.65e-06	1.44e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL6—chronic kidney failure	3.62e-06	1.43e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGS2—chronic kidney failure	3.62e-06	1.43e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOS3—chronic kidney failure	3.61e-06	1.42e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—KRAS—chronic kidney failure	3.61e-06	1.42e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	3.6e-06	1.42e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAT—chronic kidney failure	3.58e-06	1.41e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—NFKB1—chronic kidney failure	3.56e-06	1.4e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOS3—chronic kidney failure	3.54e-06	1.39e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	3.53e-06	1.39e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—chronic kidney failure	3.53e-06	1.39e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	3.53e-06	1.39e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	3.53e-06	1.39e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SERPINE1—chronic kidney failure	3.51e-06	1.38e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ALB—chronic kidney failure	3.51e-06	1.38e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—KRAS—chronic kidney failure	3.51e-06	1.38e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	3.5e-06	1.38e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	3.49e-06	1.37e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	3.48e-06	1.37e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCA1—chronic kidney failure	3.47e-06	1.37e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PPARA—chronic kidney failure	3.46e-06	1.37e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IRS1—chronic kidney failure	3.45e-06	1.36e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCA1—chronic kidney failure	3.44e-06	1.36e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—KRAS—chronic kidney failure	3.44e-06	1.35e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—KRAS—chronic kidney failure	3.42e-06	1.35e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—chronic kidney failure	3.41e-06	1.34e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RELA—chronic kidney failure	3.4e-06	1.34e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—VEGFA—chronic kidney failure	3.39e-06	1.33e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NFKB1—chronic kidney failure	3.36e-06	1.33e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NOS3—chronic kidney failure	3.36e-06	1.32e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOS3—chronic kidney failure	3.35e-06	1.32e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—VEGFA—chronic kidney failure	3.35e-06	1.32e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—KRAS—chronic kidney failure	3.35e-06	1.32e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—KRAS—chronic kidney failure	3.34e-06	1.31e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RELA—chronic kidney failure	3.33e-06	1.31e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—chronic kidney failure	3.33e-06	1.31e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—LPL—chronic kidney failure	3.32e-06	1.31e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—IL6—chronic kidney failure	3.31e-06	1.31e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL6—chronic kidney failure	3.27e-06	1.29e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—chronic kidney failure	3.25e-06	1.28e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	3.21e-06	1.26e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IGF1—chronic kidney failure	3.2e-06	1.26e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NFKB1—chronic kidney failure	3.18e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—KRAS—chronic kidney failure	3.18e-06	1.25e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—KRAS—chronic kidney failure	3.16e-06	1.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RELA—chronic kidney failure	3.16e-06	1.24e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAT—chronic kidney failure	3.12e-06	1.23e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—chronic kidney failure	3.11e-06	1.22e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL6—chronic kidney failure	3.09e-06	1.22e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—chronic kidney failure	3.08e-06	1.21e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGS2—chronic kidney failure	3.07e-06	1.21e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—VEGFA—chronic kidney failure	3.05e-06	1.2e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SERPINE1—chronic kidney failure	3.04e-06	1.2e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—IL6—chronic kidney failure	3.02e-06	1.19e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	3e-06	1.18e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	2.99e-06	1.18e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAT—chronic kidney failure	2.94e-06	1.16e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—IL6—chronic kidney failure	2.94e-06	1.16e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PPARA—chronic kidney failure	2.93e-06	1.16e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	2.92e-06	1.15e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	2.92e-06	1.15e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAT—chronic kidney failure	2.92e-06	1.15e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOS3—chronic kidney failure	2.9e-06	1.14e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—LPL—chronic kidney failure	2.89e-06	1.14e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—VEGFA—chronic kidney failure	2.89e-06	1.14e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—KRAS—chronic kidney failure	2.88e-06	1.13e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NFKB1—chronic kidney failure	2.87e-06	1.13e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCB1—chronic kidney failure	2.86e-06	1.13e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—chronic kidney failure	2.85e-06	1.12e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—KRAS—chronic kidney failure	2.85e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCB1—chronic kidney failure	2.84e-06	1.12e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—chronic kidney failure	2.82e-06	1.11e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NFKB1—chronic kidney failure	2.81e-06	1.11e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—chronic kidney failure	2.8e-06	1.1e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—chronic kidney failure	2.79e-06	1.1e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	2.79e-06	1.1e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—chronic kidney failure	2.79e-06	1.1e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—KRAS—chronic kidney failure	2.75e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—chronic kidney failure	2.74e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RELA—chronic kidney failure	2.73e-06	1.08e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—chronic kidney failure	2.73e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—LPL—chronic kidney failure	2.73e-06	1.07e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—chronic kidney failure	2.71e-06	1.07e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LPL—chronic kidney failure	2.7e-06	1.06e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	2.7e-06	1.06e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	2.67e-06	1.05e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NFKB1—chronic kidney failure	2.66e-06	1.05e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—chronic kidney failure	2.65e-06	1.05e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	2.63e-06	1.04e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	2.62e-06	1.03e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	2.61e-06	1.03e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—chronic kidney failure	2.6e-06	1.03e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VEGFA—chronic kidney failure	2.6e-06	1.03e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—KRAS—chronic kidney failure	2.6e-06	1.02e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—chronic kidney failure	2.59e-06	1.02e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALB—chronic kidney failure	2.58e-06	1.01e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—chronic kidney failure	2.57e-06	1.01e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPARA—chronic kidney failure	2.56e-06	1.01e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VEGFA—chronic kidney failure	2.55e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	2.55e-06	1e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—KRAS—chronic kidney failure	2.54e-06	1e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—FASN—chronic kidney failure	2.49e-06	9.83e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NOS3—chronic kidney failure	2.46e-06	9.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—KRAS—chronic kidney failure	2.46e-06	9.68e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—chronic kidney failure	2.45e-06	9.67e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—chronic kidney failure	2.43e-06	9.59e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VEGFA—chronic kidney failure	2.42e-06	9.52e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPARA—chronic kidney failure	2.41e-06	9.49e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—chronic kidney failure	2.39e-06	9.42e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—chronic kidney failure	2.39e-06	9.42e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPARA—chronic kidney failure	2.39e-06	9.41e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—chronic kidney failure	2.34e-06	9.23e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—chronic kidney failure	2.34e-06	9.22e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—chronic kidney failure	2.32e-06	9.14e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NFKB1—chronic kidney failure	2.3e-06	9.07e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	2.27e-06	8.95e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—chronic kidney failure	2.25e-06	8.88e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—chronic kidney failure	2.24e-06	8.81e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—chronic kidney failure	2.22e-06	8.74e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—KRAS—chronic kidney failure	2.21e-06	8.72e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALB—chronic kidney failure	2.18e-06	8.59e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—KRAS—chronic kidney failure	2.17e-06	8.54e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—chronic kidney failure	2.11e-06	8.32e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VEGFA—chronic kidney failure	2.09e-06	8.23e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NOS3—chronic kidney failure	2.09e-06	8.22e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—chronic kidney failure	2.08e-06	8.21e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—chronic kidney failure	2.06e-06	8.13e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—KRAS—chronic kidney failure	2.05e-06	8.1e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—chronic kidney failure	2e-06	7.88e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—chronic kidney failure	1.96e-06	7.74e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—chronic kidney failure	1.95e-06	7.67e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—chronic kidney failure	1.92e-06	7.58e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—chronic kidney failure	1.92e-06	7.56e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	1.91e-06	7.52e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALB—chronic kidney failure	1.9e-06	7.48e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.87e-06	7.37e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NOS3—chronic kidney failure	1.82e-06	7.16e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—chronic kidney failure	1.8e-06	7.1e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALB—chronic kidney failure	1.79e-06	7.05e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LPL—chronic kidney failure	1.78e-06	7.02e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—KRAS—chronic kidney failure	1.78e-06	7e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALB—chronic kidney failure	1.77e-06	6.99e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—chronic kidney failure	1.76e-06	6.95e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.72e-06	6.78e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NOS3—chronic kidney failure	1.71e-06	6.75e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NOS3—chronic kidney failure	1.7e-06	6.69e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—chronic kidney failure	1.67e-06	6.59e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—chronic kidney failure	1.66e-06	6.55e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.6e-06	6.32e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.57e-06	6.2e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—chronic kidney failure	1.57e-06	6.17e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—chronic kidney failure	1.55e-06	6.12e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—chronic kidney failure	1.45e-06	5.69e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—chronic kidney failure	1.28e-06	5.06e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALB—chronic kidney failure	1.17e-06	4.61e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	1.12e-06	4.41e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	1.02e-06	4.03e-06	CbGpPWpGaD
